Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
NCT03214081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1237
Last updated 2025-06-10
Summary
The purpose of this survey is to evaluate the safety and effectiveness of long-term administration of vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine clinical settings.
Conditions
- Reflux Esophagitis
Interventions
- DRUG
-
Vonoprazan
Vonoprazan tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-01
- Primary Completion
- 2018-08-31
- Completion
- 2018-08-31
Countries
- Japan
Study Locations
More Related Trials
-
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis
NCT01459367 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on Vonoprazan in the Real-world Clinical Practice in China
NCT04501627 ·Status: COMPLETED
-
Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis
NCT01452776 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
NCT05055128 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis
NCT01452698 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
NCT05343364 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
NCT01286194 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
NCT04799158 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)
NCT00236392 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
NCT04124926 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
NCT00216489 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
NCT00132496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
NCT06106022 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT02954848 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
NCT00787891 ·Status: COMPLETED ·Phase: PHASE3
-
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
NCT05634187 ·Status: COMPLETED
-
TAK-438 - Safety, Blood Levels & Effects of Repeated Doses
NCT02141711 ·Status: COMPLETED ·Phase: PHASE1
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
NCT02615184 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease
NCT01135368 ·Status: COMPLETED ·Phase: PHASE4
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00911534 ·Status: COMPLETED ·Phase: PHASE3
-
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
NCT02351960 ·Status: COMPLETED ·Phase: PHASE4
-
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
NCT00770913 ·Status: COMPLETED ·Phase: PHASE2/PHASE3